Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary H Lyman

Showing results (11-20 of 442) with videos related to

Pageof 45
Sort By:
Journal of Oncology Practice|September 13, 2017
Emerging Opportunities and Challenges of Biosimilars in Oncology PracticeGary H Lyman
Journal of Oncology Practice|September 22, 2010
Journal of oncology practice in transitionGary H Lyman
Journal of Oncology Practice|September 22, 2010
ASCO Clinical Practice Guidelines: Past, Present and FutureGary H Lyman
Cancer|March 23, 2011
Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxisGary H Lyman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Appropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancerGary H Lyman
Oncology (Williston Park, N.Y.)|August 29, 2009
The road to romiplostim approval and beyondGary H Lyman
Cancer Investigation|February 5, 2010
Anthracyclines in the treatment of early-stage breast cancer: ally or adversary?Gary H Lyman
Clinical Advances in Hematology & Oncology : H&O|November 16, 2019
How biosimilars will impact costs and care in oncologyGary H Lyman
Medical Care|June 23, 2005
Time is money for both the healthy and the sickGary H Lyman
Journal of Oncology Practice|November 28, 2012
Weight-based chemotherapy dosing in obese patients with cancer: back to the futureGary H Lyman
Pageof 45

Showing results (11-20 of 442) with videos related to

Sort By:
Pageof 45
Journal of Oncology Practice|September 13, 2017
Emerging Opportunities and Challenges of Biosimilars in Oncology PracticeGary H Lyman
Journal of Oncology Practice|September 22, 2010
Journal of oncology practice in transitionGary H Lyman
Journal of Oncology Practice|September 22, 2010
ASCO Clinical Practice Guidelines: Past, Present and FutureGary H Lyman
Cancer|March 23, 2011
Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxisGary H Lyman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Appropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancerGary H Lyman
Oncology (Williston Park, N.Y.)|August 29, 2009
The road to romiplostim approval and beyondGary H Lyman
Cancer Investigation|February 5, 2010
Anthracyclines in the treatment of early-stage breast cancer: ally or adversary?Gary H Lyman
Clinical Advances in Hematology & Oncology : H&O|November 16, 2019
How biosimilars will impact costs and care in oncologyGary H Lyman
Medical Care|June 23, 2005
Time is money for both the healthy and the sickGary H Lyman
Journal of Oncology Practice|November 28, 2012
Weight-based chemotherapy dosing in obese patients with cancer: back to the futureGary H Lyman
Pageof 45